双边内部乳腺动脉移植是否会降低冠状动脉复发的长期风险? 一个多中心分析

Alexander Iribarne1, Joseph D Schmoker2, David J Malenka2

  • 1From Department of Surgery, Section of Cardiac Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH (A.I., D.J.M., J.N.M., J.P.D., E.M.O., A.W.D.); Department of Medicine, Section of Cardiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH (D.J.M.); Department of Surgery, Section of Cardiac Surgery, University of Vermont Medical Center, Burlington (J.D.S., B.J.L.); Department of Surgery, Section of Cardiac Surgery, Central Maine Medical Center, Lewiston (P.W.W.); Department of Surgery, Section of Cardiac Surgery, Catholic Medical Center, Manchester, NH (B.M.W.); Department of Surgery, Section of Cardiac Surgery, Maine Medical Center, Portland (R.D.Q., R.S.K.); Department of Surgery, Section of Cardiac Surgery, Eastern Maine Medical Center, Bangor (J.D.K.); and Department of Surgery, Section of Cardiac Surgery, Concord Hospital, NH (G.L.S.). alexander.iribarne@hitchcock.org.

Circulation
|November 1, 2017
PubMed
概括

与单个内部乳腺动脉 (SIMA) 移植相比,双边内部乳腺动脉 (BIMA) 移植减少了重复冠状动脉再血管化的需要. 这种改善的长期存活率和降低的复血管化风险表明,在冠状动脉旁路移植中,应更频繁地考虑使用BIMA.

相关概念视频